Jun. 30 at 1:29 PM
$HEPA Couldn't have happened to a nicer guy!
Item 5.02 Departure of Directors or Certain Officers: Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On June 25, 2025, John Brancaccio, the CFO and a director of Hepion Pharmaceuticals, Inc., a Delaware corporation (the "Company”), resigned as CFO and a director,
effective June 30, 2025 for personal reasons.